Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Antibiotics
- What are antibiotics?
- Some definitions
- How do we measure antibiotic activity?
- Where do antibiotics come from?
- Antibiotics as natural products
- Antibiotic discovery timeline
- The consequence of antibiotic discovery
- New diseases and old diseases coming back
- How do antibiotics work?
- Antibiotic targets: Gram positive
- Antibiotic targets: Gram negative
- Major antibiotic classes
- Antibiotic resistance
- The problem
- Mechanisms of resistance
- Permeability
- Antibiotic efflux
- MFS efflux
- SMR efflux
- RND efflux
- ABC efflux
- Antibiotic modifying enzymes
- Beta-Lactams
- Beta-Lactamases
- Mechanisms of beta-Lactamases
- ESBLs
- KPC beta-Lactamases
- Metallo beta-Lactamases
- Aminoglycosides
- Structure of aminoglycosides
- Tetracyclines
- Rifamycins
- Antibiotic resistance by target modification
- Glycopeptide antibiotics
- Glycopeptide resistance in VRE
- Antibiotic resistance by other means
- Quinolones
- Trimethoprim-Sulfa
- MDR = combinatorial resistance
- There is a great need for new antimicrobials
Topics Covered
- Antibiotics
- What are they and short history
- Mechanism of action
- Mechanisms of antibiotic resistance
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Wright, G. (2009, October 29). Antibiotics and antibiotic resistance [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 7, 2024, from https://doi.org/10.69645/ALON8405.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Gerry Wright has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Microbiology
Transcript
Please wait while the transcript is being prepared...
0:00
Hi, I'm Gerry Wright from McMaster University in Hamilton, Ontario.
In this lecture, I will discuss antibiotics and
antibiotic resistance and provide you with an overview of these two areas.
0:13
The talk will be divided into two sections.
In the first, we'll discuss what antibiotics
are and how they work, and in the second one,
we'll cover various modes of antibiotic resistance and discuss in some detail,
some specific classes of resistance and their genes.
0:29
So first section one, antibiotics.
What are they and how do they work?
0:35
First, what are antibiotics?
Well, antibiotics are small molecules.
By small molecules, we mean molecules that have a molecular mass of less than
3,000 Daltons to distinguish them from larger macromolecules like proteins.
They block the growth of microorganisms,
including bacteria and fungi.
This growth inhibition can result in the death of the cell.
In these cases, we call them bactericidal or in the case of fungi,
fungicidal compounds, or they can simply stop the cells from growing.
These will be called static molecules, bacteriostatic or fungistatic.
1:13
First, let's start with some definition.
Antibiotics rigorously are natural products that inhibit the growth of bacteria.
These are molecules like penicillin and erythromycin.
By natural products, we mean molecules that are produced by living systems.
Genetically encoded small molecule.
Antibacterial agents would include compounds that are not natural products of it,
that is synthesized by chemists that also have those similar kinds of properties.
Ciprofloxacin is a good example of it.
However, over the years,
the term antibiotics has served to cover both of these areas.
Although in the literature you may see
antibacterial agents being distinguished from antibiotics from this one.
Anti-infective agents include antibiotics and antibacterial agents,
and any compound that will inhibit the growth of a microorganism.
So this includes antifungals,
anti-parasitic agents, and even antiviral.
Another term that is often used in the field, is spectrum.
A broad-spectrum antibiotic impacts many microbial species.
Whereas a narrow-spectrum antibiotic,
has some selectivity towards just a few species are general.
In order to discuss antibiotic activity and antibiotic resistance,